Skip to main content

SOPHiA GENETICS SA

SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
SEC CIK
0001840706

In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.

Q1 2022 vs. Q4 2021

How the institutions holding SOPHiA GENETICS SA changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of SOPH: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders3229−3
Shares18.6M21.7M+3.04M (+16.3%)
Value$262.5M$167.5M−$95.0M (−36.2%)

New holders (7)

Institutions that held SOPHiA GENETICS SA at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to SOPH in Q1 2022
InstitutionSharesValue% of portfolio
Banque Pictet & Cie SA2,096,420$16.2M0.13%
Pura Vida Investments, LLC829,930$6.42M0.78%
Pictet & Cie (Europe) SA227,600$1.76M0.07%
Manufacturers Life Insurance Company, The72,069$604.0K0.00%
Bank Pictet & Cie (Asia) Ltd64,420$498.0K0.14%
Assetmark, Inc210$2.00K0.00%
TCWP LLC30$00.00%

Sold out (10)

Institutions that held SOPHiA GENETICS SA at the end of Q4 2021 and filed for Q1 2022 without it.